Mathijs van Oevelen1, Alferso C Abrahams2, Willem Jan W Bos3,4, Mariëlle H Emmelot-Vonk5, Simon P Mooijaart6, Merel van Diepen7, Brigit C van Jaarsveld8, Anita van Eck van der Sluijs2, Carlijn G N Voorend3, Marjolijn van Buren3,9. 1. Department of Internal Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. M.van_Oevelen@lumc.nl. 2. Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Department of Internal Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. 4. Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands. 5. Department of Geriatrics, University Medical Center Utrecht, Utrecht, The Netherlands. 6. Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands. 7. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. 8. Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, The Netherlands. 9. Department of Nephrology, Haga Hospital, The Hague, The Netherlands.
Abstract
BACKGROUND: The incidence and prevalence of older patients with kidney failure who are dependent on dialysis is increasing. However, observational studies showed limited or no benefit of dialysis on mortality in subgroups of these patients when compared to conservative care. As the focus is shifting towards health-related quality of life (HRQoL), current evidence of effects of conservative care or dialysis on HRQoL in older patients is both limited and biased. Dialysis comes with both high treatment burden for patients and high costs for society; better identification of patients who might not benefit from dialysis could result in significant cost savings. The aim of this prospective study is to compare HRQoL, clinical outcomes, and costs between conservative care and dialysis in older patients. METHODS: The DIALysis or not: Outcomes in older kidney patients with GerIatriC Assessment (DIALOGICA) study is a prospective, observational cohort study that started in February 2020. It aims to include 1500 patients from 25 Dutch and Belgian centres. Patients aged ≥70 years with an eGFR of 10-15 mL/min/1.73m2 are enrolled in the first stage of the study. When dialysis is initiated or eGFR drops to 10 mL/min/1.73m2 or lower, the second stage of the study commences. In both stages nephrogeriatric assessments will be performed annually, consisting of questionnaires and tests to assess most common geriatric domains, i.e. functional, psychological, somatic, and social status. The primary outcome is HRQoL, measured with the Twelve-item Short-Form Health Survey. Secondary outcomes are clinical outcomes (mortality, hospitalisation, functional status, cognitive functioning, frailty), cost-effectiveness, and decisional regret. All outcomes are (repeated) measures during the first year of the second stage. The total follow-up will be a maximum of 4 years with a minimum of 1 year in the second stage. DISCUSSION: By generating more insight in the effects of conservative care and dialysis on HRQoL, clinical outcomes, and costs, findings of this study will help patients and physicians make a shared decision on the best individual treatment option for kidney failure. TRIAL REGISTRATION: The study was registered in the Netherlands Trial Register ( NL-8352 ) on 5 February 2020.
BACKGROUND: The incidence and prevalence of older patients with kidney failure who are dependent on dialysis is increasing. However, observational studies showed limited or no benefit of dialysis on mortality in subgroups of these patients when compared to conservative care. As the focus is shifting towards health-related quality of life (HRQoL), current evidence of effects of conservative care or dialysis on HRQoL in older patients is both limited and biased. Dialysis comes with both high treatment burden for patients and high costs for society; better identification of patients who might not benefit from dialysis could result in significant cost savings. The aim of this prospective study is to compare HRQoL, clinical outcomes, and costs between conservative care and dialysis in older patients. METHODS: The DIALysis or not: Outcomes in older kidney patients with GerIatriC Assessment (DIALOGICA) study is a prospective, observational cohort study that started in February 2020. It aims to include 1500 patients from 25 Dutch and Belgian centres. Patients aged ≥70 years with an eGFR of 10-15 mL/min/1.73m2 are enrolled in the first stage of the study. When dialysis is initiated or eGFR drops to 10 mL/min/1.73m2 or lower, the second stage of the study commences. In both stages nephrogeriatric assessments will be performed annually, consisting of questionnaires and tests to assess most common geriatric domains, i.e. functional, psychological, somatic, and social status. The primary outcome is HRQoL, measured with the Twelve-item Short-Form Health Survey. Secondary outcomes are clinical outcomes (mortality, hospitalisation, functional status, cognitive functioning, frailty), cost-effectiveness, and decisional regret. All outcomes are (repeated) measures during the first year of the second stage. The total follow-up will be a maximum of 4 years with a minimum of 1 year in the second stage. DISCUSSION: By generating more insight in the effects of conservative care and dialysis on HRQoL, clinical outcomes, and costs, findings of this study will help patients and physicians make a shared decision on the best individual treatment option for kidney failure. TRIAL REGISTRATION: The study was registered in the Netherlands Trial Register ( NL-8352 ) on 5 February 2020.
Entities:
Keywords:
Costs and cost analysis; Dialysis; Frailty, geriatric assessment; Kidney failure, chronic; Mortality; Quality of life
Authors: N Berkhout-Byrne; A Gaasbeek; M J K Mallat; T J Rabelink; S P Mooijaart; F W Dekker; M van Buren Journal: Neth J Med Date: 2017-07 Impact factor: 1.422
Authors: Mathijs van Oevelen; Alferso C Abrahams; Willem Jan W Bos; Mariëlle H Emmelot-Vonk; Simon P Mooijaart; Merel van Diepen; Brigit C van Jaarsveld; Anita van Eck van der Sluijs; Carlijn G N Voorend; Marjolijn van Buren Journal: BMC Nephrol Date: 2021-03-29 Impact factor: 2.388
Authors: Mathijs van Oevelen; Alferso C Abrahams; Willem Jan W Bos; Tiny Hoekstra; Marc H Hemmelder; Marc Ten Dam; Marjolijn van Buren Journal: Nephrol Dial Transplant Date: 2021-11-09 Impact factor: 5.992
Authors: Carlijn G N Voorend; Mathijs van Oevelen; Wouter R Verberne; Iris D van den Wittenboer; Olaf M Dekkers; Friedo Dekker; Alferso C Abrahams; Marjolijn van Buren; Simon P Mooijaart; Willem Jan W Bos Journal: Nephrol Dial Transplant Date: 2022-07-26 Impact factor: 7.186
Authors: Carlijn G N Voorend; Hanneke Joosten; Noeleen C Berkhout-Byrne; Adry Diepenbroek; Casper F M Franssen; Willem Jan W Bos; Marjolijn Van Buren; Simon P Mooijaart Journal: Eur Geriatr Med Date: 2021-04-19 Impact factor: 1.710